Event Contacts
Katherine Ford
katherine.ford@stjude.org
Anita White
anita.white@stjude.org
Zane Coleman
zane.coleman@stjude.org
The Science of Childhood Cancer is an interactive, weekly lecture series designed to engage the scientific community on key questions in pediatric cancer research. The 2024 lecture season begins February 8 and runs through May 16. You may register below for future seasons of the series, hosted by the St. Jude Comprehensive Cancer Center.
Invited speakers are leading experts across the spectrum of basic, translational, clinical and population science. The Rising Stars of Cancer Research lecture in the 15-week series will feature thematically related talks by two early- to mid-career investigators conducting exciting and innovative work in the field.
Lectures occur each Thursday from 12 pm – 1 pm Central time / 1 pm – 2 pm Eastern time and are often followed by an extended Q&A session. Available recordings will be posted here in the week following the live event.
Hosts
-
- Executive Vice President
- Director, Comprehensive Cancer Center
-
- Deputy Director, Comprehensive Cancer Center
- Co-Leader, Hematological Malignancies Program
- Medical Director, St. Jude Biorepository
Upcoming lectures
March 21, 2024
Understanding treatment resistance and relapse in ALL through single cell studies
Kara Davis, DO
Stanford University
March 28, 2024
Stem cell programs in high risk leukemias
Kai Tan, PhD
Professor of Pediatrics, Richard & Sheila Sanford Endowed Chair
Children’s Hospital of Philadelphia
University of Pennsylvania Perelman School of Medicine
April 4, 2024
Quality of care for adolescents and young adults with advanced cancer
Jenny Mack, MD, MPH
Associate Professor of Pediatrics
Harvard Medical School
Associate Chief, Division of Population Sciences, Division of Population Sciences, Faculty Vice President for the Office for Faculty Development, Professionalism, and Inclusion
Dana-Farber Cancer Institute
April 11, 2024
Targeting metabolic vulnerabilities in high-risk childhood cancer using immunotherapy (and other modalities)
Poul Sorensen, BSc, MD, PhD, FRCPC
Professor, Department of Pathology & Laboratory Medicine
The University of British Columbia
April 18, 2024
Novel therapeutic targets in T-cell Leukemia
Daniel Herranz, PharmD, PhD
Associate Professor of Pharmacology and Pediatrics
Rutgers Cancer Institute of New Jersey
April 25, 2024
Accelerating therapeutic innovations for children and adolescents with cancer
Gilles Vassal, MD, PhD
Gustave Roussy Comprehensive Cancer Center, Villejuif, France
May 2, 2024
Metabolism and epigenetics as integrated drivers of childhood brain cancer
Sriram Venneti, MD, PhD
Associate Professor of Pathology and Pediatrics; Al and Robert Glick Family Research Professor of Pediatrics; Scientific Research Director
Chad Carr Pediatric Brain Tumor Center, University of Michigan Medical School
May 9, 2024
Poverty as a "druggable" target: opportunities and challenges for health equity research
Kira Bona, MD, MPH
Assistant Professor of Pediatrics
Harvard Medical School
Attending Physician, Pediatric Oncology
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Guideline development and delivery of precision-survivorship care
Matt Ehrhardt, MD, MS
Associate Member
St. Jude Children's Research Hospital
May 16, 2024
Moving Beyond the Cure
Heather Conklin, PhD
Chief, Division of Neuropsychology; Full Member, Department of Psychology and Biobehavioral Sciences
St. Jude Children’s Research Hospital
Comprehensive Cancer Center
St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.